CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


19-January-2016
Cerilliant introduces Certified Spiking Solutions® of MAM2201 & AB-PINACA 5-Hydroxypentyl metabolite. 

MAM2201 S-091
100 µg/mL in Methanol

A certified solution standard suitable for use in LC/MS or GC/MS synthetic cannabinoid testing applications including clinical toxicology, forensic analysis, and urine drug testing. MAM2201 is a hybrid of the synthetic cannabinoids JWH-122 and AM-2201. This drug has been identified in European synthetic cannabinoid blends.
For those synthetic cannabinoids currently controlled at the federal level, our certified solution standards of these substances are DEA-exempt, allowing laboratories to place orders without additional regulatory paperwork. For US customers, state specific regulatory requirements may apply.  

AB-PINACA 5-Hydroxypentyl S-084
100 ug/mL in Methanol

A major metabolite of AB-PINACA, a synthetic cannabinoid commonly found in a variety of black market drug products marketed as herbal smoking blends. This monohydroxy analog is also referred to as the omega-hydroxy metabolite of AB-PINACA.

For those synthetic cannabinoids currently controlled at the federal level, our certified solution standards of these substances are DEA-exempt, allowing laboratories to place orders without additional regulatory paperwork. For US customers, state specific regulatory requirements may apply.



Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn